FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Caraco Pharmaceutical Laboratories Venlafaxine Hydrochloride Extended-Release Recall

Venlafaxine Hydrochloride Extended-Release Tablets, 150 mg, Rx only, Packaged in 30 Cou…

Caraco Pharmaceutical Laboratories, Ltd. · Detroit, MI

Risk level
Class II
Reported by FDA
Jul 9, 2014
Recall ID
D-1415-2014
Check your lot numberHow we source this data

Summary

Caraco Pharmaceutical Laboratories recalled Venlafaxine Hydrochloride Extended-Release starting Jun 12, 2014. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1415-2014 on Jul 9, 2014. Reason: Failed Dissolution Specifications: Stability results found the product did not meet the drug dissolution specifications. Status: Terminated.

Why it was recalled

Failed Dissolution Specifications: Stability results found the product did not meet the drug dissolution specifications.

Product description

Venlafaxine Hydrochloride Extended-Release Tablets, 150 mg, Rx only, Packaged in 30 Count and 90 Count Bottles. Distributed by: Caraco Pharmaceutical Laboratories, Ltd., 1150 Elijah McCoy Drive, Detroit, MI 48202; Manufactured at: Sun Pharmaceutical Ind. Ltd., Halol-Baroda Highway, Halol-389 350, Gujarat, India. 30-Count Bottle NDC: 41616-758-83, 90-Count Bottle: NDC 41616-758-81.

Lot numbers, UPCs & expiration codes

30 Count Bottle: Lot #: JKL5054A, Expiry: 08/2014; Lot #: JKM2305A, Expiry: 03/2015. 90 Count Bottle: Lot #: JKL5054B, Expiry: 08/2014; Lot #: JKM2305B, Expiry: 03/2015.

Where it was sold

Nationwide including Puerto Rico

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1415-2014
Classification
Class II
Status
Terminated
Recall initiated
Jun 12, 2014
FDA report date
Jul 9, 2014
Quantity
26,530 30-Count Bottles; 14,597 90-Count Bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Caraco Pharmaceutical Laboratories, Ltd.

Original FDA data

Every field from FDA enforcement report D-1415-2014, exactly as published.

Show all FDA fields
City
Detroit
State
MI
Status
Terminated
Country
United States
Event ID
68637
Address
1150 Elijah McCoy Dr
Code information
30 Count Bottle: Lot #: JKL5054A, Expiry: 08/2014; Lot #: JKM2305A, Expiry: 03/2015. 90 Count Bottle: Lot #: JKL5054B, Expiry: 08/2014; Lot #: JKM2305B, Expiry: 03/2015.
Postal code
48202-3344
Report date
Jul 9, 2014
Product type
Drugs
Recall number
D-1415-2014
Classification
Class II
Recalling firm
Caraco Pharmaceutical Laboratories, Ltd.
Product quantity
26,530 30-Count Bottles; 14,597 90-Count Bottles
Termination date
May 6, 2015
Reason for recall
Failed Dissolution Specifications: Stability results found the product did not meet the drug dissolution specifications.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Venlafaxine Hydrochloride Extended-Release Tablets, 150 mg, Rx only, Packaged in 30 Count and 90 Count Bottles. Distributed by: Caraco Pharmaceutical Laboratories, Ltd., 1150 Elijah McCoy Drive, Detroit, MI 48202; Manufactured at: Sun Pharmaceutical Ind. Ltd., Halol-Baroda Highway, Halol-389 350, Gujarat, India. 30-Count Bottle NDC: 41616-758-83, 90-Count Bottle: NDC 41616-758-81.
Distribution pattern
Nationwide including Puerto Rico
Recall initiation date
Jun 12, 2014
Initial firm notification
Letter
Center classification date
Jul 2, 2014

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1415-2014, published Jul 9, 2014. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls